Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy
Several mutations identified in phospholamban (PLN) have been linked to familial dilated cardiomyopathy (DCM) and heart failure, yet the underlying molecular mechanism remains controversial. PLN interacts with sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and regulates calcium uptake, which is mod...
Main Authors: | Juan Qin, Jingfeng Zhang, Lianyun Lin, Omid Haji-Ghassemi, Zhi Lin, Kenneth J Woycechowsky, Filip Van Petegem, Yan Zhang, Zhiguang Yuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/75346 |
Similar Items
-
Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review
by: Andreea Sorina Afana, et al.
Published: (2024-01-01) -
Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
by: Arianne Caudal, et al.
Published: (2022-08-01) -
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation
by: Tim R. Eijgenraam, et al.
Published: (2022-02-01) -
SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin‐deficient mice
by: Jessica L. Braun, et al.
Published: (2019-08-01) -
Phospholamban R14del disease: The past, the present and the future
by: Elizabeth Vafiadaki, et al.
Published: (2023-04-01)